The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Trasylol 10,000 KIU/ml, solution for injection or infusion

Nordic Group B.V.PA2252/001/001

Main Information

Trade NameTrasylol 10,000 KIU/ml, solution for injection or infusion
Dosage FormSolution for injection/infusion
Licence HolderNordic Group B.V.
Licence NumberPA2252/001/001

Group Information

ATC CodeB02AB Proteinase inhibitors
B02AB01 aprotinin


License statusAuthorised
Licence Issued29/03/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back